DOI: https://doi.org/10.36347/sjmcr.2025.v13i10.091

Pages: 2567-2571

Anogenital condylomas, or genital warts, are benign lesions caused by infection with the human papillomavirus (HPV), primarily genotypes 6 and 11. Although they are not associated with malignant transformation unlike oncogenic HPV types these low-risk viral strains cause significant morbidity due to their frequency and impact on patients’ quality of life. HPV infection is among the most common sexually transmitted infections (STIs) worldwide, with most sexually active individuals likely to be infected at some point in their lives. Condylomas are the most visible clinical manifestation of HPV infection and can affect the genital, anal, and even oral mucosal regions, with a higher prevalence among young adults. Transmission occurs mainly through skin-to-mucosa contact during sexual activity, even without penetration. The often-asymptomatic nature of the infection, its long incubation period, and the possibility of latent carriage make epidemiological control difficult. Diagnosis may be delayed or missed, especially in cases of atypical lesions or those located in areas not easily accessible to clinical examination. From a therapeutic standpoint, management of condylomas remains a challenge. While several treatment options exist topical, destructive, or surgical none completely eradicates the virus, and recurrences are common. Moreover, the psychological burden of the disease, often underestimated, underscores the need for a comprehensive approach including education, prevention, and psychological support.